VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization
暂无分享,去创建一个
Raghu Kalluri | Rajan Dewar | Hikaru Sugimoto | V. LeBleu | R. Kalluri | R. Brentani | Vesselina G. Cooke | R. Rocha | E. Neilson | R. Dewar | M. Zeisberg | Michael Zeisberg | Ricardo R Brentani | Joyce T. O’Connell | Vesselina G Cooke | Ankit I Mehta | Valerie S. LeBleu | Eric G Neilson | B. Macdonald | Ankit I. Mehta | Joyce T O'Connell | Brian A MacDonald | Valerie S LeBleu | Rafael M Rocha | Murray B Resnick | H. Sugimoto | M. Resnick | V. Cooke
[1] P. Rudland,et al. Increased abundance of a normal cell mRNA sequence accompanies the conversion of rat mammary cuboidal epithelial cells to elongated myoepithelial-like cells in culture. , 1984, Nucleic acids research.
[2] J. Swiergiel,et al. A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein. , 1987, Nucleic acids research.
[3] J. Savin,et al. Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. , 1987, Journal of molecular biology.
[4] E. Shooter,et al. Nerve growth factor induces the genes for two proteins related to a family of calcium-binding proteins in PC12 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Grigorian,et al. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. , 1989, Genes & development.
[6] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[7] H. Hidaka,et al. Isolation and characterization of a calcium-binding protein derived from mRNA termed p9Ka, pEL-98, 18A2, or 42A by the newly synthesized vasorelaxant W-66 affinity chromatography. , 1992, Archives of biochemistry and biophysics.
[8] F. Strutz,et al. Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.
[9] H. Tamaki,et al. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] R. Rubin. The war on cancer. , 1996, U.S. news & world report.
[11] E. Hovig,et al. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. , 1996, Cancer research.
[12] M. Grigorian,et al. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells , 1996, International journal of cancer.
[13] Yohko Nakamura,et al. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells , 1997, Oncogene.
[14] K. Wada,et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] J. Monson,et al. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer , 2000, British Journal of Cancer.
[16] J. Winstanley,et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. , 2000, Cancer research.
[17] A. Fischer,et al. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] E. Neilson,et al. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. , 2003, Cancer research.
[19] F. Kabbinavar,et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[21] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[22] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[23] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[24] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[25] K. Miller. E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer. , 2003, Clinical breast cancer.
[26] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[27] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[28] D. Horsfall,et al. Expression of Extracellular Matrix Components Versican, Chondroitin Sulfate, Tenascin, and Hyaluronan, and Their Association with Disease Outcome in Node-Negative Breast Cancer , 2004, Clinical Cancer Research.
[29] D. Helfman,et al. The metastasis associated protein S100A4: role in tumour progression and metastasis , 2005, British Journal of Cancer.
[30] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[31] M. Grigorian,et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.
[32] J. Myklebust,et al. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer , 2007, International journal of cancer.
[33] E. Perez,et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. , 2007, The New England journal of medicine.
[34] V. A. Flørenes,et al. Different Expression and Clinical Role of S100A4 in Serous Ovarian Carcinoma at Different Anatomic Sites , 2009, Tumor Biology.
[35] B. Nielsen,et al. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. , 2010, Cancer research.
[36] J. Sleeman,et al. Cancer metastasis as a therapeutic target. , 2010, European journal of cancer.
[37] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.